Blogs about: Xx Therapeutic Platform
Featured Blog
RegImmune, Inc.: Series B $4.2M
RegImmune (Mountain View, CA) technology platform named reVax is targeting various allergic and immune diseases, with lead indications in allergies and organ rejection has raised a $4.2M Series B roun… more →
OnBioVC
4-Antibody AG: Series A $18.5M
arubenstein wrote 2 years ago: 4-Antibody (Basel, Switzerland) a biopharmaceutical company developing optimal therapeutic antibody … more →
